Genome Research Facts

Illumina was founded in 1998. Our first products and services were based on the BeadArray Technology. In 2001, the FastTrack Genotyping service was launched for research use only. Since then, Illumina technology has expanded, providing researchers with genetic analysis tools used to uncover information about the human genome at an unprecedented pace.

International HapMap Project: A scientific collaboration with the goal of developing a public catalog of genetic variation patterns that will help researchers find genes associated with human disease and response to pharmaceuticals. Illumina's technology was used to generate approximately 70% of the first phase.
1000 Genomes Project: A collaboration research effort involving groups in the U.S., U.K., China, and Germany that aims to produce complete human genome sequences for >1,200 individuals. It will extend the data from the International HapMap Project to support further medical research studies.
The Cancer Genome Atlas: A comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of genome analysis technologies. The overarching goal of The Cancer Genome Atlas is to improve the ability to diagnose, treat, and prevent cancer.

First Name: *
Last Name: *
Country: *
Email: *
Reason for Inquiry: *
Comments:

SUBMIT

Illumina

This lab developed test was developed, and its performance characteristics were determined, by the Illumina Clinical Services Laboratory (CLIA-certified, CAP-accredited). Consistent with lab developed tests, it has not been cleared or approved by the U.S. Food and Drug Administration. You will not receive from Illumina medical results, or a diagnosis, or recommendation for treatment. Please note that Illumina does not accept orders for Individual Genome Sequencing services from the following states: Florida, Maryland, New York, and Rhode Island.